top of page

    AGENDA

    Friday, March 29, 2019

     

     

    12:00 – 12:50 PM

    Lunch
     

    12:50 – 1:00 PM

    Welcome/Introduction
    Conference Chairs: Lawrence Schiller, MD and Mack Miller, MD​

     

    Current Topics in Hepatology I 
    Moderator: Nancy Reau, MD

     

    1:00 – 1:25 PM

    HBV: Which treatments are currently available and what is on the horizon?
    Nancy Reau, MD


    1:25 – 1:50 PM

    HCV Elimination: Screening, linkage and treatment
    Eric Lawitz, MD


    1:50 – 2:15 PM

    PBC: Screening, diagnosis and treatment
    Naim Alkhouri, MD


    2:15 – 2:40 PM

    NAFLD/NASH: Screening, current management and treatments on the horizon

    Mack Mitchell, MD


    2:40 – 3:00 PM

    Q&A/Panel Discussion
     

    3:00 – 3:15 PM

    Break*

     

    Current Topics in Gastroenterology I
    Moderator: William Chey, MD
     

    3:15 – 3:45 PM

    Evidence based medical management of IBS
    William Chey, MD


    3:45 – 4:15 PM

    Management of acute pancreatitis in accordance with quality measures
    Paul Tarnasky, MD


    4:15 – 4:45 PM

    Chronic abdominal pain: Making a diagnosis and what to do when you can't

    Lawrence Schiller, MD
     

    4:45 – 5:15 PM

    Q&A/Panel Discussion


    5:15 – 5:30 PM

    Day 1 Wrap-up
    Conference Chair: Lawrence Schiller, MD


    5:30 – 7:00 PM

    Welcome Reception*

     

    Saturday, March 30, 2019

     

     

    7:30 – 8:20 AM

    Breakfast/Optional Symposium* 

    (Non-Accredited)
     

    8:20 – 8:30 AM

    Welcome
    Conference Chairs: Lawrence Schiller, MD and Mack Miller, MD​

     

    Current Topics in Gastroenterology II  
    Moderator: Michael Vaezi, MD, PhD

     

    8:30 – 8:55 AM
    Impact of bariatric surgery on esophageal function and GERD

    Michael Vaezi, MD, PhD


    8:55 – 9:20 AM

    Treatment of non-achalasia motor disorders (EGJ outlet obstruction, spasm and jackhammer)
    Joel Richter, MD


    9:20 – 9:45 AM

    Endoscopic therapy for GERD
    Ronnie Fass, MD

     

    9:45 – 10:10 AM

    Q&A/Panel Discussion


    10:10 – 10:25 AM

    Break*

     

    10:25 – 11:25 AM

    Parallel Sessions (Attendees select one of the following)

    • GI Woes From Head to Toe

    • Inflammatory Bowel Disease/Colorectal Cancer

    • Viral Hepatitis/Cholestatic Disease/Non-alcoholic Fatty Liver Disease

    • Complications of Cirrhosis with Focus on Hepatic Encephalopathy,
      thrombocytopenia and Hepatocellular Carcinoma

     

    11:25 AM – 12:25 PM

    Lunch/Optional Symposium*

    (Non-Accredited)

     

    Plenary Session (Ethics Credit)
     

    12:25 – 1:10 PM

    The Compassionate Practice
    Evonne Kaplan-Liss, MD, MPH

    Current Topics in Hepatology II 
    Moderator: Kimberly Brown, MD 

     

    1:10 – 1:35 PM

    Management of complications of cirrhosis: Hepatic encephalopathy and thrombocytopenia
    Kimberly Brown, MD

     

    1:35 – 2:00 PM

    Hepatocellular carcinoma: Screening and treatment
    Amit Singal, MD

     

    2:20 – 2:35 PM

    Q&A/Panel Discussion


    2:35 – 2:50 PM

    Break*


    Current Topics in Gastroenterology III  
    Moderator: Stephen Hanauer, MD

     

    2:50 – 3:15 PM

    IBD: Transforming guidelines and pathways into practice
    Stephen Hanauer, MD


    3:15 – 3:40 PM

    Management of IBD complications including iron-deficiency anemia
    Amar Deshpande, MD


    3:40 – 4:05 PM

    Value based care in GI including colon cancer screening
    Deepak Agrawal, MD, MPH, MBA 


    4:05 – 4:35 PM

    Q&A/Panel Discussion


    4:35 – 4:40 PM

    Closing Remarks

     

    *Exhibits will be located in the Salon Foyer throughout the duration of the conference. 

     

    Please note this agenda is subject to change. 

     

    Click here to download a copy of our agenda!

     

    TM

    This activity is supported by educational grants from AbbVie, Gilead,
    Intercept Pharmaceuticals, Inc., Prometheus Laboratories Inc., and Salix Pharmaceuticals.

    Annenberg.png

    Jointly provided by the Annenberg Center for Health Sciences at Eisenhower,
    the Gastrointestinal and Liver Association of the Americas (GALA),
    and the Texas Liver Institute.

    TLI.png
    bottom of page